Skip to content

Delphinus Medical Technologies

4 viewers · 30d

Total raised

$27.6M

1 filing since 2024 · latest SAFE filed

Cumulative raised
LAST ROUND
SAFE · $27.6M
ROUNDS
1
INVESTORS
8
FOUNDED
N/A
HQ
Novi, MI
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
4

AI overview

Updated

Delphinus Medical Technologies, Inc. is a pioneering medical imaging firm based in Novi, Michigan, dedicated to transforming breast cancer screening, especially for women with dense breast tissue. The company is renowned for developing the SoftVue™ system, which utilizes advanced ultrasound technology to improve cancer detection and streamline the screening process.

What sets it apart

Delphinus stands out due to its innovative SoftVue™ system, which provides a radiation-free and non-compressive breast cancer screening option that significantly enhances detection rates in women with dense breast tissue.

Funding history

1 round
SAFE+1Mar 22, 2024
Form D/A
+$27.6M$27.6M total

Latest SEC filings

via EDGAR · CIK 0001492534
Form D/A · Mar 22, 2024View on EDGAR

Products

1 tracked

SoftVue™ 3D Whole Breast Ultrasound Tomography System

Breast Cancer Screening

The SoftVue™ system is an FDA-approved medical device that utilizes revolutionary circular array transducer technology to produce three-dimensional whole breast ultrasound images. The device uniquely employs sound and water for imaging, avoiding the discomfort associated with compression and the risks related to radiation exposure found in traditional mammography.

  • Non-invasive and comfortable – no compression or radiation
  • Quick scanning – complete breast scans in just 2-3 minutes
  • Enhanced cancer detection – identifies up to 20-25% more cancers when used with mammography
  • FDA approval validating its safety and efficacy